[Treatment of nonalcoholic steatohepatitis (NASH)].
Nakashima
Toshiaki
T
Department of Internal Medicine, Saiseikai Kyoto Hospital.
Sumida
Yoshio
Y
Mitsuyoshi
Hironori
H
Okanoue
Takeshi
T
D003545:Cysteine / Q000627:therapeutic use; D004032:Diet; D004338:Drug Combinations; D005234:Fatty Liver / Q000628:therapy*; D005998:Glycine / Q000627:therapeutic use; D006505:Hepatitis / Q000628:therapy*; D006801:Humans; D007333:Insulin Resistance; D016031:Liver Transplantation; D009765:Obesity / Q000178:diet therapy; D009828:Oleanolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D004338:Drug Combinations; D014810:Vitamin E; D009828:Oleanolic Acid; C009781:neominophagen C; D014580:Ursodeoxycholic Acid; D003545:Cysteine; D005998:Glycine